Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shinobu Yamamichi"'
Autor:
Junya Saito, Mio Yamashima, Toshiya Hayashida, Tomonari Ikeda, Satoshi Ishida, Tatsuki Urakawa, Takuma Okamura, Yasutaka Kuribayashi, Shinobu Yamamichi, Hiroyuki Yajima, Osamu Miyazaki, Tetsuro Honda, Ryuichi Sugiyama, Tomoko Kiyohara, Ryosuke Suzuki, Hiroyuki Moriuchi, Tatsuki Ichikawa
Publikováno v:
Kanzo. 63:500-503
Autor:
KAZUYOSHI NAGATA, RYU SASAKI, SHINICHI IWATSU, MASANORI FUKUSHIMA, MASAFUMI HARAGUCHI, SHINOBU YAMAMICHI, SATOSHI MIUMA, HISAMITSU MIYAAKI, NAOTA TAURA, TAKUYA YAMAZAKI, KAZUHIKO NAKAO
Publikováno v:
Anticancer research. 42(10)
This study was conducted to determine the prognosis and risk factors for survival in patients treated with stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC).This retrospective study analyzed 73 patients who underwent SBRT for H
Autor:
Kazuhiko Nakao, Yasutaka Kuribayashi, Osamu Miyazaki, Mio Yamashima, Satoshi Miuma, Yasuhide Motoyoshi, Shinobu Yamamichi, Tatsuki Ichikawa, Keiji Kira, Ryouhei Uehara, Naota Taura, Hiroyuki Yajima, Yusuke Nakano, Hisamitsu Miyaaki, Makiko Koike, Tetsurou Honda
Publikováno v:
Internal Medicine
Objective Patient-reported outcomes (PROs) are important measures of the quality of life (QOL) and symptoms in patients with hepatitis C virus (HCV). We evaluated the PROs at the beginning of direct-acting antiviral (DAA) treatment and three years la
Autor:
Osamu Miyazaki, Naoyuki Hino, Tatsuki Ichikawa, Ryousuke Hirata, Tetsurou Honda, Mio Yamashima, Ryouhei Uehara, Kazuhiko Nakao, Satoshi Miuma, Hiroyuki Yajima, Naota Taura, Shinobu Yamamichi, Hisamitsu Miyaaki, Yasuhide Motoyoshi, Makiko Koike
Publikováno v:
Hepatology Research. 50:704-714
Aim Sarcopenia is a harmful condition in patients with chronic liver disease. However, the evaluation of body muscle mass requires expensive instrumentation. The sarcopenia index (SI): (creatinine / cystatin C × 100) has been reported to correlate w
Autor:
Yasuhide Motoyoshi, Hisamitsu Miyaaki, Makiko Koike, Hiroyuki Yajima, Tatsuki Ichikawa, Yusuke Nakano, Osamu Miyazaki, Yasutaka Kuribayashi, Kazuhiko Nakao, Mio Yamashima, Ryouhei Uehara, Satoshi Miuma, Shinobu Yamamichi, Keiji Kira, Naota Taura, Tetsurou Honda
Publikováno v:
Biomedical Reports
A simple method is required to screen for sarcopenia in patients with chronic liver disease. In the present study, the value of the existing SARC-F questionnaire as well as calculated body muscle mass (CBMM) approaches were assessed for screening of
Autor:
Ryu Sasaki, Kazuyoshi Nagata, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi, Masaya Shigeno, Mio Yamashima, Shinobu Yamamichi, Tatsuki Ichikawa, Yuki Kugiyama, Hiroshi Yatsuhashi, Kazuhiko Nakao
Publikováno v:
Cancers; Volume 14; Issue 3; Pages: 827
Cancers, Vol 14, Iss 827, p 827 (2022)
Cancers, Vol 14, Iss 827, p 827 (2022)
Background: Atezolizumab plus bevacizumab therapy has high response rates in patients with unresectable hepatocellular carcinoma (HCC). The hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) has been reported to be us
Autor:
Eisuke Ozawa, Shinobu Yamamichi, Yuko Akazawa, Mio Yamashima, Kazuhiko Nakao, Yuri Miyazoe, Tomoyuki Suehiro, Ryu Sasaki, Takehiro Matsumoto, Kazuto Ashizawa, Takuya Honda, Satoshi Miuma, Suguru Nakashiki, Naota Taura, Hidetaka Shibata, Hisamitsu Miyaaki
Publikováno v:
Nutrition. 50:97-103
Objective: Arterial ketone bodies, which reflect liver function, have been investigated. However, the relationship between venous ketone bodies and hepatocellular carcinoma (HCC) is unclear. We investigated whether prognosis of patients with HCC afte
Autor:
Shinobu Yamamichi, Tatsuki Ichikawa, Satoshi Miuma, Takuma Okamura, Kazuhiko Nakao, Yasuhide Motoyoshi, Osamu Miyazaki, Yusuke Nakano, Tetsurou Honda, Makiko Koike, Naota Taura, Mio Yamashima, Hisamitsu Miyaaki, Yasutaka Kuribayashi, Tomonari Ikeda, Hiroyuki Yajima
Publikováno v:
Biomedical Reports
Hepatitis B virus (HBV) infection is associated with the risk of osteoporosis and bone mineral density (BMD) loss. Tenofovir alafenamide (TAF) is associated with a slightly lower degree of BMD loss compared with tenofovir disoproxil, without loss of
Autor:
Shinobu Yamamichi, Tatsuki Ichikawa, Naoyuki Hino, Ryousuke Hirata, Kazuhiko Nakao, Hisamitsu Miyaaki, Naota Taura, Hiroyuki Yajima, Yasuhide Motoyoshi, Youichi Takahashi, Satoshi Miuma, Makiko Koike, Ryouhei Uehara, Mio Yamashima, Tetsurou Honda
Publikováno v:
Biomedical reports. 12(3)
Serum creatinine (Cr)-based glomerular filtration rate (CrGFR) is overestimated in liver disease. The present study evaluated whether the difference in CrGFR and cystatin C (CysC) GFR (dGFR) is significant in liver disease. The Cr-to-CysC ratio and s
Autor:
Satoshi Miuma, Tatsuki Ichikawa, Hidetaka Shibata, Hisamitsu Miyaaki, Takayuki Wada, Shinobu Yamamichi, Taro Yamamoto, Naota Taura, Hiroshi Masumoto, Yasuko Kanda, Kazuhiko Nakao
Publikováno v:
Journal of viral hepatitisREFERENCES. 27(5)